Imipramine: A model drug for P450 research

被引：7

作者：

Brosen, K

Skjelbo, E

Nielsen, KK

机构：

来源：

CYTOCHROME P450, PT B | 1996年 / 272卷

关键词：

D O I：

10.1016/S0076-6879(96)72022-0

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：177 / 186

页数：10

共 18 条

[11] IMIPRAMINE METABOLISM IN RELATION TO THE SPARTEINE AND MEPHENYTOIN OXIDATION POLYMORPHISMS - A POPULATION STUDY [J].

MADSEN, H ;

NIELSEN, KK ;

BROSEN, K .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (04) :433-439

[12]

MEIER PJ, 1983, GASTROENTEROLOGY, V85, P682

[13] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF IMIPRAMINE AND 6 METABOLITES IN HUMAN PLASMA AND URINE [J].

NIELSEN, KK ;

BROSEN, K .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 612 (01) :87-94

[14] IMIPRAMINE - CLINICAL EFFECTS AND PHARMACOKINETIC VARIABILITY [J].

REISBY, N ;

GRAM, LF ;

BECH, P ;

NAGY, A ;

PETERSEN, GO ;

ORTMANN, J ;

IBSEN, I ;

DENCKER, SJ ;

JACOBSEN, O ;

KRAUTWALD, O ;

SONDERGAARD, I ;

CHRISTIANSEN, J .

PSYCHOPHARMACOLOGY, 1977, 54 (03) :263-272

[15]

SKJELBO E, 1993, BRIT J CLIN PHARMACO, V35, P331

[16] INHIBITORS OF IMIPRAMINE METABOLISM BY HUMAN LIVER-MICROSOMES [J].

SKJELBO, E ;

BROSEN, K .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :256-261

[17] THE MEPHENYTOIN OXIDATION POLYMORPHISM IS PARTIALLY RESPONSIBLE FOR THE N-DEMETHYLATION OF IMIPRAMINE [J].

SKJELBO, E ;

BROSEN, K ;

HALLAS, J ;

GRAM, LF .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (01) :18-23

[18] DETERMINATION OF IMIPRAMINE AND 7 OF ITS METABOLITES IN HUMAN LIVER-MICROSOMES BY A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD [J].

ZEUGIN, TB ;

BROSEN, K ;

MEYER, UA .

ANALYTICAL BIOCHEMISTRY, 1990, 189 (01) :99-102

← 1 2 →